Home/Filings/4/0000821616-04-000003
4//SEC Filing

HORVATH JODAN A 4

Accession 0000821616-04-000003

CIK 0000821616other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:27 PM ET

Size

12.8 KB

Accession

0000821616-04-000003

Insider Transaction Report

Form 4
Period: 2004-01-01
HORVATH JODAN A
VP & General Counsel
Transactions
  • Award

    Right to purchase

    2004-01-01+12,50012,500 total
    Exercise: $13.30Exp: 2014-01-01Common Stock, $.02 par value (12,500 underlying)
Holdings
  • Common Stock, $.02 par value

    (indirect: By 401(k))
    4,237
  • Right to purchase

    Exercise: $9.79Exp: 2012-01-03Common Stock, $.02 par value (20,000 underlying)
    20,000
  • Right to purchase

    Exercise: $7.75Exp: 2010-08-14Common Stock, $.02 par value (150,000 underlying)
    150,000
  • Right to purchase

    Exercise: $8.05Exp: 2013-01-01Common Stock, $.02 par value (25,000 underlying)
    25,000
  • Common Stock, $.02 par value

    9,300
Footnotes (5)
  • [F1]Options were granted under terms of the Company's 1991 Stock Option Plan. These options became exercisable in three equal installments on 8/14/2001, 8/14/2002, and 8/14/2003.
  • [F2]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant became exercisable in two equal installments on 1/3/2003 and 1/3/2004.
  • [F3]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in two equal installments on 1/1/2004 and 1/1/2005.
  • [F4]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in two equal installments on 5/21/2004 and 5/21/2005.
  • [F5]Options were granted under terms of the Company's 2001 Employee Stock Option Plan. Grant becomes exercisable in two equal installments on 1/1/2005 and 1/1/2006.

Issuer

BENTLEY PHARMACEUTICALS INC

CIK 0000821616

Entity typeother

Related Parties

1
  • filerCIK 0001247092

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:27 PM ET
Size
12.8 KB